RET and Hirschsprung disease: In this large case-control study, we investigated the possible role of variants in the RET proto-oncogene in cohorts of 162 Czech patients with HSCR and 205 unaffected control individuals and the role of these variants in gender manifestation differences and their influence on the aggressiveness of the disease.